Category Archives: biotechnology

Peering into the Future of Health Insurance: Real-time Data and a Whole New Way to Look at Actuarial Science

“At Lemonade…their hope is to remake insurance as a social good, rather than a necessary evil.” – Dr. Peter H. Diamandis The structure of ObamaCare® requires people who don’t have health insurance to purchase it; if you can’t afford it, … Continue reading

Posted in biotechnology, consumer health apps, electronic patient records, health economics, health insurance, health IT, health policy, health reform, healthcare change management, healthcare marketing | Leave a comment

If I could choose only one healthcare topic two months before the election, it would be…

…difficult to choose. The escalating cost of drugs is an election year favorite Then there are several reports this week that electronic health records are a PITA to doctors, and I don’t mean the kind wrapped in flatbread Let’s not … Continue reading

Posted in biotechnology, electronic patient records, health economics, health insurance, health IT, health policy, health reform, pharmaceutical sales | Leave a comment

A Yuuuuuuge Edition: Health Wonk Review Channels Inner Trump

Steve Anderson at Medicareresources.org channels his inner Trump to bring us a yuuuuuge edition of Health Wonk Review. Thanks to Steve for a tremendous undertaking in the service to his fellow countrymen and countrywomen.  

Posted in biotechnology, consumer health apps, electronic patient records, health economics, health insurance, health IT, health reform, healthcare change management, healthcare marketing, pharmaceutical marketing | Leave a comment

The Public Option or (ahem) Single-Payer: Solutions to a Growing Healthcare Monster?

Politically, I’ve been accused of being just a little to the right of Attila the Hun. That’s really not fair…to Attila. I only open with that slight bit of hyperbole to underline the fact that this is not a corner … Continue reading

Posted in biotechnology, electronic patient records, health economics, health insurance, health IT, health policy, health reform, healthcare marketing, pharmaceutical marketing | Leave a comment

A Pot Luck Health Wonk Review – Breathe This In

Chris Fleming has posted A Pot Luck Health Wonk Review at Health Affairs Blog.  Many thanks to Chris & crew for hosting a great edition – we all greatly value Health Affairs ongoing participation! As Chris said in his post, “Despite … Continue reading

Posted in biotechnology, consumer health apps, electronic patient records, health economics, health insurance, health IT, health policy, health reform | Leave a comment

Human Nucleus: Your Analyzed Individual Genome is the Basis for Population Health In Extremis

You can know and affect your health future now. Human Longevity Institute is launching Human Nucleus, a place where you can have your genome completely analyzed into its millions of component pieces of information. That information is actionable immediately, and … Continue reading

Posted in biotechnology, consumer health apps, electronic patient records, health economics, health insurance, health IT, health policy, health reform, healthcare change management | 2 Comments

Health Wonk Review, The Musical

And now, for your dancing and listening pleasure, Health Wonk Review, the musical… David Harlow of HealthBlawg’s Health Wonk Review is Bustin’ Out All Over. Hat tip to Rogers and Hammerstein. Listen here. For more Harlowfun, tune in every other … Continue reading

Posted in biotechnology, consumer health apps, elearning, electronic patient records, health economics, health insurance, health IT, health policy, health reform | Leave a comment

Health Wonk Review: The Early Bird Catches the Worm Spring Edition

Tradition is important, and it has become a Health Wonk Review tradition to have a theme for each edition. Usually, the edition’s host organizes content by topic or finds some overarching theme to propel the issue forward. In the spirit … Continue reading

Posted in biotechnology, elearning, health economics, health insurance, health policy, health reform, healthcare marketing, pharmaceutical marketing, pharmaceutical sales, training | 7 Comments

A Presidential Politics-free Health Wonk Review

Okay, people, it’s safe to come out now. Jaan Sidorov of The Population Health Blog has delivered a presidential-politics free edition of Health Wonk Review. I’m hosting the next edition in two weeks, so this may be a short reprieve. … Continue reading

Posted in biotechnology, consumer health apps, electronic patient records, health economics, health insurance, health IT, health policy, health reform, healthcare marketing, pharmaceutical marketing | Leave a comment

Behavior Change Driving Digital Health is Bubbling Up from the Bottom

This week marks one month since ePharma Summit 2016 opened and closed. It’s a good time to reflect on a final takeaway from the conference and close my notebook. Clearly, there is more grand thinking about the future and emphasis … Continue reading

Posted in biotechnology, consumer health apps, electronic patient records, health economics, health IT, health policy, health reform, healthcare change management, healthcare marketing, pharmaceutical marketing, pharmaceutical sales | 1 Comment